C 21 H 25 NO 3 , triclinic,
. 
Source of material
The title compound was synthesized according to a reported procedure [5] . A mixture of cyclohexane-1,3-dione (10 mmol), 3,4-dimethyl-benzaldehyde (10 mmol), ammonium acetate (10 mmol) and ethyl acetoacetate (10 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then cooled to room temperature. Evaporation at room temperature yielded colourless crystals of C 21 H 25 NO 3 .
Experimental details
The H atoms bonded to C and N were positioned geometrically and re ned using a riding model, with C-H = 0.93 Å and 0.86 Å and with U iso (H) = 1.2 times Ueq(C) and Ueq(N).
Discussion
4-Arylpolyhydroquinoline derivatives are one of the most commonly encountered of pharmacophores for a number of compounds having medicinal signi cance including anticancer, antiviral, antibacterial, antioxidant, anti-HIV, antihyperglycemic and anti-dyslipidemic activities [1, 2] . Recognizing the considerable importance of these compounds, research focused on the synthesis of new 4-arylpolyhydroquinoline derivatives [3, 4] . In the crystal structure of compound 1, the six-membered ring containing nitrogen is nearly planar (maximum deviation = 0.1765 Å) and the adjacent ketone ring adopts a attened chair conformation [dihedral angle (N1-C1-C 2 -C 3 ) = 161.582°]. The heterocycle is almost perpendicular to the benzene ring (dihedral angle = 89.426°) and is almost coplanar to the mean plane of the ketone ring (dihedral angle = 10.555°).
